Related Experiment Video
Updated: Apr 11, 2026

A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting
Published on: November 20, 2015
Annexin A4 and cancer
Bin Wei1, Chunmei Guo1, Shuqing Liu2
1Department of Biotechnology, Dalian Medical University, Dalian 116044, China.
Annexin A4 (Anxa4) shows varied roles in cancer, promoting tumor growth in many but suppressing it in prostate cancer. Understanding Anxa4
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Annexin A4 (Anxa4) is a calcium-regulated, phospholipid-binding protein belonging to the annexin superfamily.
- Anxa4 is implicated in the diagnosis, prognosis, and therapeutic strategies for various human malignancies.
Purpose of the Study:
- To review and discuss the clinical significance of Anxa4 in oncogenesis.
- To explore the potential mechanisms underlying Anxa4's diverse roles in different cancer types.
Main Methods:
- Literature review of studies investigating Anxa4 expression and function in cancer.
- Synthesis of findings on Anxa4's role as an oncogene, tumor suppressor, or diagnostic marker.
Main Results:
- Anxa4 upregulation correlates with tumor progression and chemoresistance in colorectal, esophageal, endometrial, gastric, lung, mesothelioma, renal, ovarian, cholangiocarcinoma, liver, breast, and laryngeal cancers.
- Anxa4 may act as a tumor suppressor in prostate cancer and has a paradoxical role in pancreatic cancer.
- Differential Anxa4 expression aids in distinguishing major salivary gland tumors from thyroid cancer and is linked to chemoresistance and metastasis in oral squamous cell carcinoma and glioma.
Conclusions:
- Anxa4 exhibits complex and context-dependent roles in cancer, acting as an oncogene in some and a tumor suppressor in others.
- Further research into Anxa4's mechanisms is crucial for developing targeted cancer therapies and diagnostic tools.
- Anxa4's differential expression patterns offer potential for cancer subtyping and predicting treatment response.
More Related Videos
12:14CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
Published on: June 2, 2022
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Cell Migration through Invadopodia
Selectins
Cancer
Abnormal Proliferation